Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01164124 · ClinicalTrials.gov registry record · Phase 2
Probiotics-Supplemented Feeding in Extremely Low Birth Weight Infants
A Phase 2 study, sponsored by Vermont Oxford Network.
- Completed
- Registry status
- Phase 2
- Development phase
- 101
- Enrollment target
NCT01164124 is a Phase 2 study that has completed, run by Vermont Oxford Network. The registered enrollment target is 101 participants.
The verdict
NCT01164124, a Phase 2 study, has completed, sponsored by Vermont Oxford Network.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 101 participants
- Enrollment target
Study Summary
The overall purpose of this research is to test whether adding a supplement to the feeding of extremely low birth weight infant (infants weighing less than 2 pound 2 oz at birth) will help him/her achieve full feeding faster and achieve better weight gain.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Probiotic supplementation (Lactobacillus rhamnosus GG and Bifidobacterium infantis)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01164124
The ClinicalTrials.gov registry entry for NCT01164124 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vermont Oxford Network, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01164124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01164124 about?
NCT01164124 is a clinical study titled "Probiotics-Supplemented Feeding in Extremely Low Birth Weight Infants". The overall purpose of this research is to test whether adding a supplement to the feeding of extremely low birth weight infant (infants weighing less than 2 pound 2 oz at birth) will help him/her achieve full feeding faster and achieve better weight gain.
What is the current status of trial NCT01164124?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 101 participants. The study started on 2008-02. Estimated completion is 2009-08.
What interventions are being tested in trial NCT01164124?
The interventions under investigation include: Placebo (OTHER), Probiotic supplementation (Lactobacillus rhamnosus GG and Bifidobacterium infantis) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01164124?
This trial is sponsored by Vermont Oxford Network, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.